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The recent availability of somatic haploid cell lines
has provided a unique tool for genetic studies in
mammals. However, the percentage of haploid cells
rapidly decreases in these cell lines, which we
recently showed is due to their overgrowth by diploid
cells present in the cultures. Based on this property,
we have now performed a phenotypic chemical
screen in human haploid HAP1 cells aiming to iden-
tify compounds that facilitate the maintenance of
haploid cells. Our top hit was 10-Deacetyl-bacca-
tin-III (DAB), a chemical precursor in the synthesis
of Taxol, which selects for haploid cells in HAP1
and mouse haploid embryonic stem cultures. Inter-
estingly, DAB also enriches for diploid cells in mixed
cultures of diploid and tetraploid cells, including in
the colon cancer cell line DLD-1, revealing a general
strategy for selecting cells with lower ploidy in mixed
populations of mammalian cells.INTRODUCTION
With a few exceptions like wasps or mites, haploidy in animals is
confined to the germline (Wutz, 2014). A diploid genome in-
creases genetic diversity and buffers the impact of mutations
due to the presence of two copies of each gene. However, this
feature has also limited genetic screenings in mammalian cells
until recently, which were more efficiently conducted in model
organisms that can grow as haploids such as yeast. Accordingly,
the isolation of animal haploid somatic cell lines has been some-
thing attempted since the 1960s with initial efforts focusing on
frogs and insects (Debec, 1978; Freed, 1962; Freed and
Mezger-Freed, 1970). Through parthenogenesis (triggering
development of unfertilized oocytes) or androgenesis (develop-This is an open access article under the CC BY-Nment of zygotes only containing a paternal genome), haploid
mammalian embryonic stem cells (haESCs) have now been suc-
cessfully derived from a wide range of species including zebra-
fish, mouse, rat, pig, monkey, and humans (Elling et al., 2011;
Leeb and Wutz, 2011; Sagi et al., 2016; Yang et al., 2013; Yi
et al., 2009). In addition to haESCs, a cell line (KBM7) harboring
a near-haploid genome except for two copies of chromosome 8
was isolated from a leukemia patient (Andersson et al., 1995).
KBM7 cells were subsequently used for the generation of an
adherent derivative (HAP1) that has lost one copy of chromo-
some 8 and is thus virtually haploid (Carette et al., 2011). As ex-
pected, haploid mammalian cell lines rapidly became a powerful
tool for forward genetic screenings and have been successfully
used in many such approaches (Blomen et al., 2015; Carette
et al., 2011; Jae et al., 2013, 2014; Papatheodorou et al., 2011;
Rong et al., 2015; Wang et al., 2015).
Despite the usefulness of haploid cell lines, haploidy is an un-
stable state inmammalian somatic cells as these cultures rapidly
become enriched in diploids, which demands frequent sorting in
order to maintain a good percentage of haploid cells (reviewed in
Yilmaz et al., 2016). While this phenomenon was originally
thought to be a consequence of diploidization, we recently
showed that it is caused by the activation of a p53-dependent
response, which limits the viability of the haploid cells that are
progressively overgrown by diploid cells present in the cultures
(Olbrich et al., 2017). Accordingly, p53 deficiency facilitates the
maintenance of haploidy in mouse haESCs (mhaESCs) or
HAP1 cells. Besides the identification of genetic conditions
that help to stabilize the haploid state, chemical strategies could
also facilitate the maintenance of haploid cultures. While some
efforts in this area have been made, they focused on a few
selected compounds and came to opposing conclusions, as
either activating (Takahashi et al., 2014) or inhibiting (He et al.,
2017) CDK1 was reported to stabilize haploidy in mhaESCs.
We here report on a chemical screen to identify compounds
capable of facilitating the maintenance of haploid cells, both in
mhaESCs and in HAP1 cells, and that has revealed a generalCell Reports 28, 597–604, July 16, 2019 ª 2019 The Authors. 597
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. A Chemical Screen to Identify
Compounds Stabilizing Haploidy in HAP1
Cells
(A) Schematic representation of the screening pro-
cedure. tdTomato-expressing haploid (HaploidTOM)
and EGFP-expressing diploid (DiploidEGFP) HAP1
cells were mixed at a 4:1 ratio and cultured in media
supplemented individually with 977 different com-
pounds during the course of 21 days. After
this period, the percentage of HaploidTOM and
DiploidEGFP cells was evaluated by flow cytometry
and compounds either increasing or decreasing the
percentage of HaploidTOM cells were selected for
secondary validation.
(B) Graph representing the results of the screen
defined in (A), indicating the thresholds at which
compounds either increased or decreased the
percentage of haploidy in more than 30% from that
observed in control (DMSO treated) wells. The
panel represents the data from 930 compounds, as
47 chemicals killed all cells during the experiment
(see Table S1).
(C) Flow cytometry analysis of DNA content in
HAP1 cells that were sorted for haploidy by FACS
on day 0 and after 26 days of growth in the
presence of DMSO (control), DAB (10 mM), or
Diclazuril (10 mM). The fraction of haploid G1
cells is highlighted in red. One representative
example out of three independent experiments is
shown.
(D) Flow cytometry analysis of DNA content in HAP1 cells that were sorted for haploidy by FACS on day 0 and after 19 days of growth in the presence of DMSO
(control), Mevastatin (10 mM), Atorvastatin (10 mM), Lovastatin (10 mM), Fluvastatin (10 mM), or Simvastatin (10 mM). The fraction of haploid G1 cells is highlighted
in red. One representative example out of three independent experiments is shown.strategy to select for cells with lower ploidy in mixed cultures of
mammalian cells.
RESULTS AND DISCUSSION
A Chemical Screen for Drugs That Stabilize Haploidy
in HAP1 Cells
As mentioned above, we recently identified that the progressive
reduction in the percentage of haploid cells observed in haploid
mammalian cell lines is due to their outgrowth by diploid cells
existing in these cultures (Olbrich et al., 2017). Based on this
property, and in order to identify chemicals that facilitate the
maintenance of haploidy, we performed a chemical screen in
HAP1 cells using a library of 977 bioactive compounds, including
many US Food and Drug Administration (FDA)-approved agents.
To do so, haploid and diploid HAP1 cells were isolated by fluores-
cence-activated cell sorting (FACS) and subsequently infected
with lentiviruses encoding for tdTomato fluorescence protein
(TOM) or EGFP, respectively. HaploidTOM and diploidEGFP popula-
tions of HAP1 cells were then mixed at a 4:1 ratio, seeded in
96-well plates, and treated individually with the chemicals from
the library for 3 weeks (Figure 1A). During the screen, compounds
were added twice perweek and cells were split once per week. At
the endpoint of the experiment, the percentage of haploid and
diploid HAP1 cells was quantified by high-throughput flow cytom-
etry on the basis of EGFP- and TOM-positive cell fractions.
The results of the screen were plotted as the percentage of
haploid cells observed in the wells treated with compounds598 Cell Reports 28, 597–604, July 16, 2019normalized to that observed in control wells (dimethylsulfoxide
[DMSO]). This representation followed a normal distribution,
with several compounds showing a clear impact on the percent-
age of TOM-positive HAP1 cells remaining after the 3-week
period (Figure 1B). From the initial screen, we selected 37 com-
pounds that either increased (n = 19) or decreased (n = 18) the
percentage of haploid cells more than 30% from that observed
in control wells for secondary validation. To validate our hits in
an orthogonal assay, HAP1 cell cultures freshly sorted for
haploidy were grown for up to 1 month in the continuous pres-
ence of each of the 37 compounds. Two independent rounds
of validations led to the identification of seven compounds that
consistently had an effect on the percentage of haploid HAP1
cells: two that stabilized haploidy and five that led to an almost
complete loss of all haploid cells in the cultures (Figures 1C
and 1D). Remarkably, all five compounds that led to the selective
disappearance of haploid cells were statins, a widely used class
of inhibitors of the hydroxymethyl glutaryl coenzyme A reductase
(HMGCR) that are medically used for controlling cholesterol
levels (Ramkumar et al., 2016). Nevertheless, since our objective
was to identify chemicals capable of stabilizing haploidy, we
focused on this class for subsequent analyses.
10-Deacetylbaccatin-III Selects for Haploid Cells in
HAP1 and mhaESCs
The two compounds that consistently stabilized haploidy in
HAP1 cells in validation experiments were 10-Deacetylbacca-
tin-III (DAB), a natural compound isolated from the yew tree
Figure 2. DAB Facilitates theMaintenance of
Haploidy in HAP1 Cells and mhaESCs
(A) tdTomato-expressing haploid (HaploidTOM)
and EGFP-expressing diploid (DiploidEGFP) HAP1
cells were mixed at a 1:4 ratio and cultured in
media containing either DMSO (control) or DAB
(10 mM) for 18 days. After this period, DNA con-
tent, EGFP, and TOM expression were quantified
by flow cytometry. Numbers indicate the per-
centages of each population. One representative
example out of three independent experiments is
shown.
(B) Flow cytometry analysis of DNA content in
mhaESCs that was sorted for haploidy by FACS
on day 0 and after 14 days of growth in the
presence of DMSO (control) or DAB (5 mM). The
fraction of haploid G1 cells is highlighted in red.
One representative example out of two different
experiments made in independent mhaESC
clones is shown.
(C) Quantification of the number of chromosomes
found on metaphases of HAP1 cells that were
sorted for haploidy by FACS on day 0 and grown in
the presence of DMSO (control) or DAB (10 mM) for
3 weeks. The effect of the compound in a diploid
clone of HAP1 cells is show for comparison of chromosome numbers. Black lines represent mean values.
(D) Representative examples of the metaphases that can be found on HAP1 cells after 3 weeks of continuous growth in the presence of DMSO (control) or
DAB (10 mM).and that is used as a precursor in the synthesis of paclitaxel
(Guéritte-Voegelein et al., 1986), and Diclazuril, an antiparasitic
used in the prevention of bovine coccidiosis (Zechner et al.,
2015). However, while DAB was able to stabilize haploidy both
in HAP1 as well as in mhaESCs (see below), the effects of Dicla-
zuril were restricted to HAP1 cells. Thus, we selected DAB for
mechanistic studies. Of note, we also observed mild effects in
stabilizing haploidy in HAP1 cells with other compounds such
as the anticancer kinase inhibitors Regorafenib or Nilotinib (Fig-
ure S1). However, these compounds overall decrease growth
rates, which would simply slow down the overgrowth of haploid
cells by diploids.
To further define the potency of DAB in stabilizing haploidy in
mammalian cultures, we analyzed its effects in HAP1 cultures
where haploid cells were a minority within the mixed population.
To do so, haploidTOM and diploidEGFP HAP1 cells weremixed in a
1:4 ratio and grown in the presence or absence of DAB (Fig-
ure 2A). By 18 days, the population of haploidTOM cells in control
conditions had been reduced to 3% from the culture. Strikingly,
when the mixed culture was grown in the presence of DAB, the
population of haploid HAP1 cells not only did not decrease but
actually increased to 45% by day 18. We next evaluated the ef-
fect of DAB in the growth of mhaESCs, where the progressive
loss of haploid cells occurs significantly faster than in HAP1 cells
(Olbrich et al., 2017). Accordingly, in 2 weeks of culture the
haploid cells had almost disappeared from mhaESC that had
been sorted for haploid content (Figure 2B). In contrast,
mhaESCs grown in the presence of DAB for the same time
kept a significant population of haploid cells. Of note, karyotype
analyses of HAP1 cells grown in the presence of DAB for 3weeks
failed to detect any obvious evidences of chromosomal gains,
breaks, or rearrangements induced by the treatment in haploidcells (Figures 2C and 2D). Moreover, exposure to DAB did not
lead to any obvious activation of the DNA damage response in
haploid HAP1 cells as measured by evaluating the phosphoryla-
tion of histone H2AX or the incorporation rates of 5-Ethynyl-2ʹ-
deoxyuridine (EdU) (Figure S2). In summary, these experiments
confirmed that DAB facilitates the maintenance of the haploid
state in mammalian somatic cell cultures.
DAB Selects for Lower Ploidy in Mixed Cultures of
Mammalian Cells
Given that DAB selects for cells with a 1n DNA content in mixed
cultures of haploid and diploid cells, we hypothesized that this
could be a general property of the chemical to select for cells
with lower ploidy in mixed cultures of mammalian cells. To do
so, we first isolated a tetraploid population from HAP1 cultures
by FACS and evaluated the effects of DAB in these cells. Consis-
tent with our hypothesis, tetraploid HAP1 cells had nearly disap-
peared after 20 days of culture in the presence of DAB and were
replaced by diploids, which were likely contaminants carried
over during the isolation of the tetraploid fraction (Figure 3A).
To further test the effects of DAB in selecting for lower ploidy,
we infected tetraploid HAP1 cells with lentiviruses expressing
blue fluorescent protein (BFP; tetraploidBFP) and mixed them
at 1:1:1 ratio with haploidTOM and diploidEGFP HAP1 cells. In
agreement with the reduced fitness of mammalian haploid and
tetraploid cells (Olbrich et al., 2017; Pfau et al., 2016), both pop-
ulations were progressively overgrown by diploidEGFP HAP1 cells
(Figure 3B). In contrast, when the mixed cultures were grown in
the presence of DAB, these became increasingly enriched
in haploidTOM cells, followed by diploidEGFP and finally by tetra-
ploidBFP cells, confirming a general effect of DAB in selecting
for cells with lower ploidy.Cell Reports 28, 597–604, July 16, 2019 599
Figure 3. DAB Selects for Cells with Lower
Ploidy in Mixed Cultures
(A) Flow cytometry analysis of DNA content in HAP1
cells that were sorted for tetraploidy by FACS on day
0 and after 21 days of growth in the presence of
DMSO (control) or DAB (20 mM). The fraction of
tetraploid G2 cells is highlighted in blue. One
representative example out of two independent
experiments is shown.
(B) tdTomato-expressing haploid (HaploidTOM),
EGFP-expressing diploid (DiploidEGFP), and BFP-
expressing tetraploid (TetraploidBFP) HAP1 cells
were mixed at a 1:1:1 ratio and cultured in media
containing either DMSO (control) or DAB (10 mM) for
19 days. The graph represents the percentage of
HaploidTOM, DiploidEGFP, and TetraploidBFP cells at
days 0, 14, and 19.
(C) tdTomato-expressing tetraploid (TetraploidTOM)
and EGFP-expressing diploid (DiploidEGFP) MEF
cells were mixed at a 1:4 ratio and cultured in media
containing either DMSO (control) or DAB (10 mM) for
13 days. After this period, DNA content, EGFP, and
TOM expression were quantified by flow cytometry.
Numbers indicate the percentages of each popula-
tion. One representative example out of three independent experiments is shown.
(D) tdTomato-expressing tetraploid (TetraploidTOM) and EGFP-expressing diploid (DiploidEGFP) DLD-1 cells were mixed at a 1:9 ratio and cultured in media
containing either DMSO (control) or DAB (30 mM) for 23 days. After this period, DNA content, EGFP, and TOM expression were quantified by flow cytometry.
Numbers indicate the percentages of each population.To determine if the effects of DAB were not restricted to HAP1
cells, we evaluated its effects in mouse embryonic fibroblasts
(MEFs), which have a tendency to spontaneously tetraploidize.
Cultures of diploid MEF expressing EFGP and tetraploid cells
expressing tdTomato at a 1:4 ratio were grown in the presence
or absence of DAB. While, in agreement with the reduced fitness
of tetraploid mammalian cells (Pfau et al., 2016), the tetraploi-
dEGFP MEF population had decreased from 80% to 52% by
day 13, this nearly disappeared if the cultures were grown in
the presence of DAB (Figure 3C). Finally, we evaluated if these
findings were also conserved in cancer cells, as tetraploidy or
whole genome duplication has been found to be a frequent event
in cancer (Zack et al., 2013). To do so, we evaluated the effects of
DAB in the colon cancer cell line DLD-1, for which an isogenic
tetraploid derivative was recently isolated through the inhibition
of cytokinesis (Drosopoulos et al., 2014). As before, diploid
DLD-1 cells expressing EFGP were mixed in a 1:9 ratio with
tetraploid DLD-1 cells expressing tdTomato and let to grow for
23 days. While, consistent with the reduced fitness of tetraploid
cells, in control conditions the population of diploid cells
increased from the original 10% to 18%, this increased to half
of the culture when the cultures were grown in the presence of
DAB (Figure 3D). Altogether, these findings indicate that DAB
selects for cells with lower ploidy in mixed cultures of mamma-
lian cells, including cancer cells.
DAB Promotes Mitotic Arrest in a Ploidy-Dependent
Manner
Last, we sought to determine the mechanism by which DAB
works. First, given that p53 deficiency stabilizes haploidy in
mammalian cells, we evaluated the effects of DAB in HAP1 cells
in which P53 had been deleted by CRISPR-Cas9. However,600 Cell Reports 28, 597–604, July 16, 2019DAB was able to increase the fraction of haploid cells both in
wild-type and P53-deficient HAP1 cells upon 25 days in culture
(Figure S3A). Next, given that DAB is a precursor in the synthe-
sis of paclitaxel, which stabilizes microtubules by preventing
their disassembly, we explored if DAB could have similar
effects. In fact, evaluation of the intracellular distribution of
a-tubulin after microtubule depolymerization induced by a
cold shock revealed a clear effect of DAB in the microtubule
dynamics of interphase cells (Figure S3B). Since microtubule
reorganization is particularly relevant for the assembly of the
mitotic spindle, we then evaluated the effects of DAB on the
time that cells spend in mitosis. To do so, we infected haploid,
diploid, and tetraploid HAP1 cells with a histone H2B-red
fluorescent protein (RFP) fusion expressing lentivirus and
monitored the effect of DAB in these cell lines by live-cell
video-microscopy (Figure 4A). These analyses revealed that
DAB extended the duration of mitosis in all three cell lines,
with the severity of the arrest correlating with their ploidy (Fig-
ures 4A and 4B). Importantly, while most haploid cells could
overcome the mitotic arrest induced by DAB and continue
cell division, diploids and particularly tetraploid HAP1 cells pre-
sented very prolonged arrests that were often followed by cell
death. Flow cytometry analyses of DNA content confirmed
the ploidy-dependent toxic effects of DAB in HAP1 cells (Fig-
ure S4A). Accordingly, while DAB did not significantly affect
the growth of haploid HAP1 cells, it had a higher impact on
diploid and particularly tetraploid HAP1 cultures (Figure S4B).
The ploidy-dependent toxicity of DAB provides a mechanism
to explain its effects on selecting for cells with lower ploidy in
mixed cultures of mammalian cells.
Further analyses of the images from the video microscopy
experiment revealed that theextendeddurationofmitosis induced
Figure 4. DAB Impairs Mitosis in a Ploidy-Dependent Manner
(A) Schematic representation of the time spent in mitosis (red and green) or interphase (gray) in individual RFP-H2B-expressing haploid, diploid, and tetraploid
HAP1 cells grown in the presence of DMSO (control) or DAB (10 mM) for 16 h. Time spent in mitosis was defined as the time between chromosome condensation
and cytokinesis. The time between chromosome condensation and the formation of the metaphase plate is indicated in red, and from anaphase onset to
cytokinesis in green. At least 35 individual cells were analyzed per condition.
(B) Quantification of the time spent in mitosis from the experiment shown in (A). Black lines represent mean values.
(C) Degradation of cyclin B in U2OS expressing a cyclin B-mCherry fusion construct as cells quantified by live-cell imaging. The graph shows the relative
fluorescence levels of cyclin B-mCherry from nuclear envelope breakdown (NEBD) until the onset of anaphase, in cells treated with the indicated compounds.
Nocodazole was used as a positive control.
(D) tdTomato-expressing haploid (HaploidTOM) and EGFP-expressing diploid (DiploidEGFP) HAP1 cells were mixed at a 1:4 ratio and cultured in media containing
either DMSO (control) or Paclitaxel (15 nM) for 20 days. After this period, DNA content, EGFP, and TOM expression were quantified by flow cytometry. Numbers
indicate the percentages of each population.
(E) tdTomato-expressing tetraploid (TetraploidTOM) and EGFP-expressing diploid (DiploidEGFP) DLD-1 cells were mixed at a 1:9 ratio and cultured in media
containing either DMSO (control) or Paclitaxel (30 nM) for 23 days. After this period, DNA content, EGFP, and TOM expression were quantified by flow cytometry.
Numbers indicate the percentages of each population.by DAB was mainly due to an effect on the compound in delaying
the formation of ametaphase plate (Figure 4A). Accordingly, while
immunofluorescence analyses revealed normal metaphase andanaphase figures in haploid HAP1 cells treatedwith DAB,mitoses
from diploids and even more so from tetraploids revealed that
these were arrested at pro-metaphase with a high proportion ofCell Reports 28, 597–604, July 16, 2019 601
lagging chromosomes (Figure S4C). To further analyze the effects
of DAB in impairing mitotic progression, we used a U2OS cell
line stably expressing a cyclin B-mCherry fusion (Gavet and
Pines, 2010). Since cyclin B levels are highest at mitotic entry
and lowest at the onset of anaphase (Clute and Pines, 1999),
this system can be used to quantify the time needed to assemble
a complete metaphase plate. These analyses confirmed the ef-
fects of DAB in mitosis, in a manner comparable to those that
can be achieved with low doses of paclitaxel (10 nM) (Figure 4C).
Based on these findings,wehypothesized that lowdosesof pacli-
taxel could also be used to select for cells with lower ploidy.
Indeed, a low dose of paclitaxel selected for haploid cells inmixed
cultures of haploid and diploid HAP1 cells, and for diploid cells in
mixed cultures of diploid and tetraploid DLD-1 cells (Figures 4D
and 4E).
We here present our work on a chemical screen to identify
chemicals that facilitate the maintenance of haploidy in mamma-
lian cells. The paclitaxel precursor DAB fulfills this objective,
providing a useful and facile manner to overcome the progres-
sive loss of haploidy in mammalian haploid cultures. While other
compounds such as Regorafenib or Nilotinib could also moder-
ately diminish diploidization rates, these are drugs that reduce
cellular growth rates in multiple cell types, so that their effects
can be explained by a slowdown in the overgrowth of haploid
of cells by diploids, which we recently showed is the basis of
the observed diploidization in HAP1 cells and mhaESCs (Olbrich
et al., 2017). Accordingly, ‘‘diploidization’’ rates are much faster
in haploid ESCs than in HAP1 or KBM7 cells due to the faster
proliferation of stem cell cultures. Strategies that select for
haploid cells, chemical or genetic, should facilitate further
research in the biology of haploid mammalian cells, and might
enable us to overcome some of the remaining challenges such
as the generation of additional primary differentiated haploid
cell lines different to ESCs. Of note, and while we here focused
on compounds that stabilize haploidy, it is remarkable that all
chemicals having an opposite effect, namely that they accelerate
the loss of haploid cells, were statins, broadly used to lower
cholesterol levels in humans. Even if at this point we lack an
understanding for this observation, it is interesting that recent
studies have identified a particular dependency of aneuploid
cells on the biosynthesis of sphingolipids (Hwang et al., 2017;
Tang et al., 2017). To what extent lipid biosynthesis is particu-
larly relevant for cells with an altered ploidy deserves further
attention.
In regard to the mechanism of action of DAB, this compound
is normally used as a precursor in the synthesis of paclitaxel
and was not known to have biological activity. In fact, and
while the compound was included as part of an FDA-approved
library, it is not approved per se and has no medical use.
Nevertheless, we here show that DAB, while significantly less
potent than paclitaxel, does have effects on microtubule dy-
namics and mitotic progression. Of note, while we previously
observed that mhaESCs are more sensitive than diploid
mESCs to high doses of paclitaxel (Olbrich et al., 2017), it is
well documented that the suppression of microtubule dy-
namics with paclitaxel occurs at much lower concentrations
than doses needed to exert toxicity (Jordan et al., 1993).
Accordingly, the effects of DAB in selecting for cells with lower602 Cell Reports 28, 597–604, July 16, 2019ploidy can be mimicked by low doses of paclitaxel. Interest-
ingly, the ploidy dependent mitotic arrest that is observed
with DAB or low-dose paclitaxel is not detected with other
chemicals that arrest cells in mitosis such as Nocodazole or
the Eg5 kinesin inhibitor Monastrol, arguing that this effect is
not just a consequence of increasing the time cells spend in
mitosis but is specific to reagents that specifically decrease
microtubule dynamics and therefore stabilize microtubule-
kinetochore attachments (Figure S4D).
Based on all of the above, our model shows that while mild
perturbations of the mitotic spindle might be tolerated in cells
with fewer chromosomes, as all chromosomes could finally
find their way to the metaphase plate, these problems become
progressively acute as the chromosome number increases,
leading to an irreversible mitotic arrest and cell death. In support
of this concept, components of the spindle assembly checkpoint
have been shown to be dispensable in organisms with few chro-
mosomes such as flies (Buffin et al., 2007), as well as in HAP1
cells (Raaijmakers et al., 2018). Furthermore, a genome-wide
screening performed in yeast revealed that mitotic spindle dis-
turbances are preferentially essential for triploid or tetraploid
cell (Storchová et al., 2006). In conclusion, in addition to its use-
fulness for studies using haploid cells, we should note that the
capacity of DAB or low-dose paclitaxel to select for cells with
lower ploidy in mixed cultures of mammalian cells might also
be relevant in the context of cancer, as an average of 37% of
all tumors have been found to present whole-genome duplica-
tion events in recent genomic studies (Zack et al., 2013). Given
that taxanes are widely used medical compounds, we propose
to focus on low doses of paclitaxel for further studies in this di-
rection. To what extent this approach can be used as a strategy
to selectively target polyploid and aneuploid cells in cancer,
and whether this is actually beneficial or damaging, remains to
be seen.STAR+METHODS
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software/prism/
Definiens Developer XDTM software Definiens Inc. https://www.definiens.com/
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Culture
HAP1 cells (kind gift of Dr. Thijn Brummelkamp, NKI, Amsterdam) were grown in IMDM (Invitrogen) supplemented with 15% FBS
(Sigma), 1% P/S and 1%Glutamine (34). Mouse embryonic fibroblasts (MEFs) were obtained from 13.5 dpc embryos using standard
methods and cultured in DMEM (Invitrogen), 15% FBS and 0.1 mM non-essential amino acids in low-oxygen conditions. Feeder
layers were generated from MEFs grown at early passages and growth arrested by ionizing irradiation (IR) with 80 Gy for 30 min.
MEFs were immortalized by lentiviral expression of the SV40-T121 antigen following a standard protocol. Diploid and tetraploid
DLD1 cell lines were a kind gift of Spiros Linardopoulos (ICR, London, UK). Cells were cultured in RPMI, 10% FBS and 1% P/S.
HEK293T (American Type Culture Collection) cells and the CyclinB1-164-mCherry (Addgene #26063) expressing U2OS cell line
were cultured in DMEM (Invitrogen), 10% FBS and 1% P/S. The following compounds were used to treat the cells: DAB (Deacetyl-
baccatin III, S2409, Selleckchem), Paclitaxel (T7402, Sigma), Nocodazole (M1404, Sigma). A total of 5x105 cells were transfected
with 10 mg of pX330-sgRNA-p53 plasmid (sequences provided below) using the Amaxa Nucleofector kit (Reactive L, X-001 pro-
gram) to generate P53-deficient HAP1 cells.
METHODS DETAILS
Chemical Screen
HAP1 haploid cells expressing tdTomato and HAP1 diploid cells expressing EGFP were mixed in a ratio 4:1 and seeded in 96-well
plates (a total of 2500 cells per well). Cells were treated individually with a chemical library containing 977 bioactive compounds, most
of which are FDA-approved (Z145127, Selleckchem) (Table S1). The screen was carried out in duplicate. Fresh compounds were
added twice per week and cells passaged once per week. After 21 days of treatment, cells were trypsinized and 14 analyzed for
the expression of tdTomato and EGFP by high throughput flow cytometry (BD FACS Canto IITM, BD Biosciences).
Derivation and Culture of mhaESCs
mhaESCswere generated as described recently (Leeb andWutz, 2011) and cultured on feeder layers in gelatin-coated plates at 37C
in N2B27-based medium plus 1000 U/ml LIF, PD0325901 (1 mM), CHIR99021 (3 mM) and supplemented with 15% knockout serum
replacement (Invitrogen), 0.1 mM nonessential amino acids and 0.35% BSA fraction V.
Plasmids
The plasmid pX330-U6-Chimeric_BB-CBh-hSpCas9 (Addgene, 42230) (Cong et al., 2013) was used in cells for gene editing. The
sequences of the sgRNAs (pX330-CRISPRp53- F: CACCGTGAAGCTCCCAGAATGCCAG; pX330-CRISPR-p53-R: AAACCTGG
CATTCTGGAGCTTCAC) used were designed and cloned as described by using the MIT CRISPR design tool (https://portals.
broadinstitute.org/gpp/public/analysis-tools/sgrna-design). Only sgRNAs with the higher scores and lower probabilities of gener-
ating off-target effects were selected. pLenti-H2B-RFP was obtained from Dr. Marcos Malumbres (Cell Division and Cancer Group,
CNIO,Madrid). The lentiviral plasmids pLVTHM (Addgene, 12247) (Wiznerowicz and Trono, 2003), pHIV-tdTomato (Addgene, 21374),
pKLV-U6gRNA(BbsI)-PGKpuro2ABFP (Addgene, 50946) (Koike-Yusa et al., 2014) were used to express EGFP, tdTomato or BFP
fluorescent proteins after infection. All de-novo generated constructs were sequenced entirely to rule out the presence of mutations.
Lentiviral Production
Lentiviral vectors were individually co-transfected in HEK293T cells using Lipofectamine 2000 (Invitrogen) with 3rd generation pack-
aging vectors (pMDLg/RRE, Addgene #12251; pRSV-Rev, Addgene #12253 and pCMV-VSVg, kind gift of Dr. Oded Singer) toe2 Cell Reports 28, 597–604.e1–e4, July 16, 2019
generate viral supernatants (Dull et al., 1998). Lentiviral supernatants were collected 36 hours after transfection, pooled and passed
through a 0.45 mM filter to eliminate cellular debris.
Flow Cytometry
We routinely analyzed the cell cycle profiles after cell sorting and when indicated by flow cytometry. Briefly, cells were trypsinized,
stained with 10 mg/ml Hoechst 33342 for 30 minutes at 37C and the analytic flow profiles of the DNA content was recorded on a BD
FortessaTM (BD Biosciences). At the same time or independently, we monitored and recorded the percentage of the corresponding
tdTomato+, EGFP+ and BFP+ in the HAP1, DLD1 or immortalizedMEF cell populations. For the evaluation of DAB toxicity, cells were
fixed in suspension with 70% ethanol and stained with PI (100 mg/ml) for DNA content analyses.
Flow Activated Cell Sorting (FACs)
HAP1, immortalized MEFs and mhaESCs were trypsinized followed by Hoechst staining (10 mg/ml Hoechst 33342, Thermo Fisher
Scientific) for 30 minutes at 37C. Sorting for specific haploid, diploid or tetraploid cell populations was based on DNA content
and/or expression of tdTomato, EGFP or BFP on a BD InfluxTM cell sorter (BD Biosciences). In a mix culture of haploid/diploid cells,
haploids were sorted based on the G1 haploid (1n) and diploids on the G2/M diploid (4n) peaks, respectively. In a mix culture of
diploid/tetraploid cells, diploids were sorted based on the G1 diploid (2n) and G2/M tetraploid (8n) peak, respectively. After each
sort the purity of the sorted cells was carefully checked by flow cytometry analysis.
Western Blot
HAP1 cell pellets were lysed in 50mM Tris, 150mM NaCl, 1% Triton X-100 or in 50mM Tris pH 7.9/8M Urea/1%Chaps followed by
30 min of incubation time shaking at 4C. 15-25 mg of supernatants were run on precast gels and transferred for protein detection by
using the following antibodies: p53 (1:1000, Cell Signaling, #2524); CDK2 (1:2000; sc-163, Santa Cruz).
Immunofluorescence
Cells were fixed with 4% PFA followed by permeabilization with 0.1% Triton X-100. Antibodies against gH2AX (1:1000, Millipore
05-636), aTubulin (1:1000, Sigma #T9026), phospho-histone H3-Ser10 (pH3) (1:100, Millipore 06-570), anti-centromeric anti-
body (ACA, 1:500, obtained from Marco Malumbres, Cell Division and Cancer Group, CNIO, Madrid) were used. Images
were acquired using a Leica TCS-SP5 equipped with a 0.7 NA 20x oil or 1.4 NA 63x oil (HCX plan Apo CS) objective and
LAS AF 2.6 software.
High-Throughput Microscopy (HTM)
High-throughput microscopy analyses were carried out as described in (Lopez-Contreras et al., 2013). 10000 HAP1 cells were
seeded per well on mClear bottom 96-well plates (Greiner Bio-One). Immunofluorescence staining with the indicated antibodies
(gH2AX or phospho-H3) was performed (see above) and images from each well were automatically acquired using an Opera
High-Content Screening System (Perkin Elmer). The images were taken at non-saturating settings and segmented using the
DAPI staining to generate masks matching cell nuclei. The levels of EdU incorporation was measured by adding EdU to the me-
dia at a final concentration of 20 mM for 30 minutes. For EdU detection the Click-iTTMEdU Alexa Fluor imaging kit (InvitrogenTM)
was used.
Metaphase Spreads
HAP1 cells were arrested at mitosis with overnight treatment with 100 ng/ml Colcemide (GIBCO/BRL). Cells were then collected,
incubated in a hypotonic buffer (0.075 mM KCl) for 15 min at 37C and fixed with Carnoy’s buffer (methanol-glacial acetic acid,
3:1). To obtain metaphase spreads, cells were dropped on slides and stained with Giemsa solution. Images from metaphases
were captured and a minimum of 19 metaphases were analyzed.
Live Cell Imaging
To evaluate mitosis entry and duration, HAP1 cells were infected with lentiviruses encoding the histone H2B-RFP and seeded on
8 wells m-Slide (Ibidi, 80826). The day after, the cells were treated with the indicated compounds and imaged every 4 minutes for
a total of 16h with a 20x objective in a Leica DMI 6000 B system. For a more careful evaluation of mitosis, SAC-dependent time
was defined as the time from nuclear envelope breakdown (NEBD) until the observation of a metaphase plate and SAC-indepen-
dent time from metaphase plate to chromosome decondensation. At least, 35 cells were followed to evaluate the time spent in
mitosis and interphase as well as cell fate for each individual cell. To evaluate cyclin B degradation, U2OS cells expressing a
CyclinB-mCherry fusion protein were seeded on 8 wells m-Slide (Ibidi, 80826). The following day, cells were treated with the indi-
cated compounds and imaged every 4 minutes for a total of 16h in a Leica DMI 6000 B system. Cyclin B degradation was eval-
uated in cells from the NEBD, with the maximum level of cyclin B expression, until the start of anaphase, where mCherry signal
was lost entirely.Cell Reports 28, 597–604.e1–e4, July 16, 2019 e3
Cold Shock Treatment
U2OS cells were pretreated with 10 mM DAB for 1 hour at 37C. Then, cells were placed on ice and put in ice-cold media supple-
mented with HEPES (pH 7.4) for 30 min to allow microtuble depolymerization. Finally, cells were either fixed with 4% PFA or placed
back to regular media with or without 10 mM DAB at 37C and fixed after 3 min. Immunofluorescence staining was performed as
described above.
QUANTIFICATION AND STATISTICAL ANALYSIS
Where indicated, data are represented as means ± standard error of the mean. Differences between groups were evaluated by
two-way analysis of variance (ANOVA) and P values are indicated when differences between two groups were statistically significant
(< 0.05). Statistical analyses were performed using Prism 8 (GraphPad La Jolla, CA).e4 Cell Reports 28, 597–604.e1–e4, July 16, 2019
